Sterol carrier protein 2 (SCP2) is a basic intracellular protein which facilitates the in vitro intermembrane transfer of cholesterol, phospholipids and glycolipids. SCP2 was expressed in Escherichia coli, puri®ed to apparent electrophoretic homogeneity and crystallized. Single crystals were obtained by hanging-drop vapour diffusion using ammonium sulfate as precipitant. These crystals belong to space group P4 1 2 1 2 or its enantiomorph, with unit-cell parameters a = b = 57.5, c = 86.5 A Ê , and have one molecule in the crystallographic asymmetric unit. Intensity data to 1.8 A Ê resolution were collected from native SCP2 crystals using synchrotron radiation, were processed and scaled with an R linear = 4.9%.
Introduction
The intracellular sterol carrier protein 2 (SCP2), also called non-speci®c lipid-transfer protein, has been associated with lipid traf-®cking and metabolism (Wirtz, 1997) . This small basic protein of about 13 kDa is expressed in all mammalian tissues examined (Myers-Payne et al., 1996; Wirtz, 1991) and its primary structure is highly conserved among species. It is encoded by a single gene which has two initiation sites (Seedorf et al., 1994) . The translation products are a 15 kDa pre-SCP2 and a 58 kDa SCPX protein. A 20-residue leader sequence is rapidly cleaved from the pre-SCP2 after translation, yielding the mature 13.2 kDa SCP2 (Seedorf et al., 1994) . SCPX is a fusion protein between a thiolase domain and SCP2, which is located at the C-teminus (Ossendorp et al., 1991) . SCP2 carries a C-terminal peroxisomal targeting signal and has been shown to be predominantly localized in peroxisomes (Ossendorp & Wirtz, 1993) , while SCPX exclusively occurs in these organelles which are involved in the oxidative metabolism of fatty acids (Van Heusden et al. (1990) . SCP2 activates the enzymatic in vitro conversion of 7-dehydrocholesterol to cholesterol (Noland et al., 1980) , cholesterol ester-i®cation, bile acid biosynthesis and the formation of progesterone (for a review, see Pfeifer et al., 1993) . Furthermore, SCP2 catalyzes the intermembrane transfer of cholesterol, phospholipids (Bloj & Zilversmit, 1977) and glycolipids (Zilversmit, 1984) . In addition, it was found recently to bind in vitro fatty acids and fatty acyl coenzyme A, with K d values in the mM and nM ranges, respectively (Schroeder et al., 1995; Frolov et al., 1996; Stolowich et al., 1997) .
Since the discovery of SCP2 in 1968 (Wirtz & Zilversmit, 1968) , an ever-increasing number of in vitro functions has emerged; the physiological role of SCP2, however, remains elusive. In contrast to the wide array of implicated functional roles for SCP2, very little is known about the structure underlying these functions. As a ®rst step towards an understanding of the interaction of SCP2 with its various substrates, we have initiated the crystal structure determination of this unique and biologically interesting protein.
Materials and methods
Mature rabbit SCP2 cDNA was cloned into the pET 20b expression vector and the recombinant protein was expressed in Escherichia coli BL-21 cells. For the expression and puri®cation of the protein, a modi®ed protocol according to Weber et al. (1998) was used. Bacteria were grown at 310 K on standard LB medium (Life Technologies, Paisley, Scotland) containing 50 mg l À1 carbenicillin (Sigma, St Louis, USA). Protein expression was induced by addition of 2 mM isopropyl -d-thiogalactopyranoside at optical density OD 600 9 0.7. Bacteria were harvested by centrifugation 3±4 h after induction, washed and resuspended in buffer A [10 mM Tris±HCl pH 8.0, 5 mM dithiothreitol (DTT), 2 mM EDTA and 0.005% sodium azide] supplemented with 2 mM phenyl-methanesulfonyl¯uoride and 2 mM benzami-dine±HCl as protease inhibitor. Bacteria were lysed and DNA sheared by several passages through a French pressure cell at 1.38 Â 10 8 Pa. All following steps were performed at 277 K. The lysate was centrifuged for 30 min at 20 000g and the supernatant was applied to a crystallization papers DEAE±Sepharose column (Pharmacia, Uppsala, Sweden). SCP2 was eluted with buffer A in the¯ow-through and applied to a SP±Sepharose column (Pharmacia). After rinsing away unbound proteins with buffer B (10 mM Tris±HCl pH 7.0, 5 mM DTT, 2 mM EDTA, 0.005% sodium azide), bound SCP2 was eluted with a linear NaCl gradient (0.1±0.3 M) in buffer B. Fractions (10 ml) containing SCP2 were concentrated to about 3.0 ml by ultra®ltration using a YM3 membrane from Amicon (Amicon, Beverly, USA), with a nominal molecular-weight cutoff of 3000. This concentrate was loaded onto a Sephadex G-75 column (Pharmacia) and eluted with buffer B. Pure SCP2 fractions were concentrated as above. The purity of the resulting protein was examined by sodium dodecyl sulfate±polyacrylamide gel electrophoresis (SDS±PAGE), isoelectric focusing gel electrophoresis (IEF) and matrix-assisted laser desorption ionization mass spectrometry (MALDI±MS). For the IEF, special ampholytes in the pI range 9±11 (Fluka, Buchs, Switzerland) and 8±10.5 (Pharmacia) had to be used owing to the high pI (about 10) of rabbit SCP2. The protein was concentrated to about 10 mg ml À1 , stored at 277 K in buffer B and subsequently used for crystallization experiments. Protein concentration was determined by the Bradford method (Bradford, 1976) using bovine serum albumin as reference protein.
Initial crystallization conditions were established using the sparse-matrix screening approach of Jancarik & Kim (1991) within the Crystal Screen I kit (Hampton Research), in conjunction with the hanging-drop vapourdiffusion technique. Standard solutions were used at room temperature and 277 K. After optimization, a suitable cryoprotectant was found by soaking crystals in equilibrated crystallization liquor which contained increasing concentrations of various carbohydrates, glycerol, alcohols or PEGs. Crystals werē ash-frozen in a N 2 stream at 103 K and tested on a rotating-anode generator using Cu K radiation with an Stoe imaging plate. A partial diffraction data set with crystals obtained from the Crystal Screen I kit was collected on the BL1 beamline of the Swiss±Norwegian beamline (! = 0.873 A Ê ) at the ESRF in Grenoble. A data set from improved crystals was collected on the BW7A beamline (! = 0.8345 A Ê ) at the EMBL Outstation at DESY, Hamburg at 100 K using a MAR Research imaging-plate system. Oscillation pictures were taken for 40 s with an oscillation range of 1.0 and a crystal-to-detector distance of 290 mm. Indexing and processing of the diffraction data was performed with the HKL package (Otwinowski & Minor, 1997) . Intensities were converted to structurefactor amplitudes using the program TRUNCATE (French & Wilson, 1978) within the CCP4 (Collaborative Computational Project, Number 4, 1994) suite of programs.
Conclusions
Expression of the 13.2 kDa rabbit SCP2 protein was achieved in Escherichia coli and the expressed protein was puri®ed by ionexchange chromatography. The yield was about 7 mg of puri®ed protein from 1 l bacterial culture. The protein was of high purity as judged by SDS±PAGE, IEF and MALDI±MS (Fig. 1) . A single band was found on both electrophoresis gels stained with Coomassie blue (Fig. 1) . A single major peak was obtained with MALDI±MS, corresponding to the calculated mass of the protein within the estimated error. The additional minor band (Fig. 1) corresponding to a smaller mass probably results from proteolytic cleavage of one or two amino acids at the C-or N-terminus of the protein. From the above methods, the protein was estimated to be about 98% pure.
Small needle-like crystals (form I) were obtained at 277 K with 2.0 M ammonium sulfate as precipitant (Fig. 2) . These crystals grew in clusters making it dif®cult to isolate single crystals. The 3.5 A Ê resolution obtained with these crystals (which lasted only about 15 min at 277 K in the beam) was improved to 3.0 A Ê at 105 K with synchrotron radiation using sucrose as a cryo-protectant. A few oscillation images could be collected, but the limited number of single crystals did not allow us to collect a complete data set. A crystal cell was established belonging to the tetragonal crystal system. Systematic extinctions of the 00l and h00 zone and merging of symmetry-equivalent intensities suggested the space group to be either P4 1 2 1 2 or its enantiomorph P4 3 2 1 2. Improved crystallization conditions (2.0 M ammonium sulfate, 300 mM lithium sulfate and 100 mM citrate buffer pH 6.5 at 277 K) resulted in chunky crystals (form II, Fig. 2) which diffracted considerably better than the initial crystals. Like the needle-like crystals, these crystals only lasted for a few minutes at ambient temperatures when exposed to X-rays; therefore, cryo-conditions had to be used. A diffraction data set was collected from one single crystal treated crystallization papers with 30% sucrose as cryo-protectant to 1.8 A Ê resolution utilizing synchrotron radiation. These crystals have practically the same unit-cell dimensions as the initial crystals (a = b = 57.5, c = 86.5 A Ê ) and belong to the same space group, as deduced from systematic extinctions and scaling results. A calculated Matthews volume (Matthews, 1968 ) of 2.7 A Ê 3 Da À1 implies that there is one molecule per asymmetric unit, corresponding to a solvent content of about 54%. The processing and scaling statistics are summarized in Table 1 and show that the data are of high quality and are almost complete, even in the highest resolution shell.
About four years ago, other workers obtained SCP2 crystals which diffracted to about 3.5 A Ê resolution (K. Wu È thrich, personal communication), but no X-ray structure has so far been reported. Presumably, the limited resolution and/or highradiation sensitivity of the crystals did not allow the structure solution. We attribute our success in obtaining high-resolution data of good quality from SCP2 crystals to two factors. Firstly, the protein samples were of high purity, as judged by gel electrophoresis methods and MALDI±MS. Secondly, suitable cryo-conditions could be established, allowing us to collect diffraction data without observing signi®cant radiation damage.
An NMR determination of the secondary structure of SCP2 has been performed showing that the protein contains a unique fold with a ®ve-stranded -sheet and three -helices (Szyperski et al., 1993) . In contrast, the last 20 amino acids at the C-terminus appear to lack secondary-structural elements. To date, no tertiary structure of this class of protein or any other homologous protein is available which could allow us to approach the structure determination by the molecular-replacement method. Therefore, we are currently in the process of screening for heavy-atom derivatives in order to solve the crystal structure of SCP2 by the MIR method.
Figure 2
Crystals of puri®ed rabbit SCP2. (a) Crystal form I; the size of the largest single crystal is about 0.5 Â 0.1 Â 0.1 mm. (b) Crystal form II; these crystals appear in two morphologically different forms within 2±3 months, after a protein precipitate has been formed which gives rise to a cloudy appearance of the solution. The form with the square face and the form with the rounded edges are isomorphous and diffract to the same resolution limit. The size of the largest crystal is about 0.3 Â 0.3 Â 0.2 mm.
